Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION OF M 2026-04-26 19:00 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION OF M
Investment Committee Memorandum | CA | 50 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION OF M

CCN 053042 | RIVERSIDE, CA | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION OF M is a 50-bed suburban community hospital in RIVERSIDE, CA with $25.0M in net patient revenue and a -2.8% operating margin. The hospital serves a payer mix of 39.8% Medicare, 6.8% Medicaid, and 53.4% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.8% to 4.6% (+736bps).

Net Revenue HCRIS$25.0M
Current EBITDA COMPUTED$-693K
Operating Margin COMPUTED-2.8%
Occupancy HCRIS73.0%
Revenue / Bed COMPUTED$500K
Net-to-Gross HCRIS62.7%
Distress Probability ML48.5%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
104
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -2.8% places it above the state median. Among 104 size-comparable peers (25-100 beds), the median margin is -5.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 104 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)CA50$25.0M-2.8%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
KFH - FREMONTCA100$296.2M-6.6%
ADVENTIST HEALTH SONORACA84$274.3M-7.4%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
WOODLAND HEALTHCARECA74$211.5M-3.2%
FRENCH HOSPITAL MEDICAL CENTERCA98$208.6M-2.1%
PALOMAR MEDICAL CENTER POWAYCA95$203.9M-3.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$525K+210bp18mo
Cost to Collect4.5%2.5%$500K+200bp12mo
Denial Rate Reduction12.0%6.5%$495K+198bp12mo
A/R Days Reduction5200.0%3800.0%$304K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$525K
Cost to Collect
$500K
Denial Rate Reduction
$495K
A/R Days Reduction
$304K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$-693K
+ RCM Uplift+$1.8M
Pro Forma EBITDA$1.1M
Current Margin-2.8%
Pro Forma Margin4.6%
WC Released (1x)$959K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.1M$13.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.1M$14.9M0.00x-100.0%
Bull Case9.0x11.0x$-959K$20.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-959K$22.2M0.00x-100.0%
Bear Case11.0x10.0x$-1.2M$5.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.2M$5.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 104 hospitals with 25-100 beds
  • Same-state prioritization (n=105)
  • Comp margins: P25=-19.6% / P50=-5.1% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.